Background & Aims: We investigated the expression of estrogen receptor (ER)
alpha and beta subtypes in cholangiocytes of normal and bile duct-ligated
(BDL) vats and evaluated the vole and mechanisms of estrogens in the modula
tion of cholangiocyte proliferation. Methods: ER-alpha and ER-beta weve ana
lyzed by immunohistochemistry, reverse-transcription polymerase chain react
ion, and Western blotting in normal and BDL rats. The effects of the ER ant
agonists tamoxifen and ICI 182,780 on cholangiocyte proliferation were eval
uated. Results: Cholangiocytes expressed both ER-alpha and ER-beta subtypes
, whereas hepatocytes expressed only ER-alpha. In association with a marked
cholangiocyte proliferation and with enhanced estradiol serum levels, the
immunoreactivity for ER-alpha involved a 3-fold higher percentage of cholan
giocytes in 3-week BDL than in normal rats; immunoreactivity for ER-beta sh
owed a 30-fold increase. Western blot analysis showed that during BDL, the
total amount of ER-beta in cholangiocytes was markedly increased (5-fold),
whereas that of ER-alpha decreased slightly (-25%). Treatment with tamoxife
n or ICI 182,780 of 3-week BDL vats inhibited cholangiocyte proliferation a
nd induced overexpression of Fas antigen and apoptosis in cholangiocytes. I
n vitro, 17 beta estradiol stimulated proliferation of cholangiocyte, an ef
fect blocked to the same extent by tamoxifen or ICI 182,780. Conclusions: T
his study suggests that estrogens and their receptors play a role in the mo
dulation of cholangiocyte proliferation.